Showing results (31-40 of 205) with videos related to
Sort By:
Pageof 21
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Vaccines for colorectal cancer and renal cell carcinomaKatherine Kabaker, Kathryn Shell, Howard L KaufmanChinese Clinical Oncology|May 10, 2017
Next generation approaches for tumor vaccinationAnand Patel, Howard L Kaufman, Mary L DisisSurgical Oncology Clinics of North America|November 21, 2007
Cytokine therapy for cancerSeunghee Kim-Schulze, Bret Taback, Howard L KaufmanCurrent Treatment Options in Oncology|March 18, 2015
Oncolytic virus immunotherapy for melanomaNeal Dharmadhikari, Janice M Mehnert, Howard L KaufmanNature Reviews. Drug Discovery|March 26, 2019
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew ZlozaExpert Review of Anticancer Therapy|October 16, 2004
Adjuvant therapy for malignant melanomaJohn P Stoutenburg, Beth Schrope, Howard L KaufmanMethods in Enzymology|March 4, 2020
Generation and validation of recombinant herpes simplex type 1 viruses (HSV-1) using CRISPR/Cas9 genetic disruptionPraveen K Bommareddy, Cole Peters, Howard L KaufmanNature Reviews. Drug Discovery|September 2, 2015
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew ZlozaCancer Treatment and Research|November 26, 2015
Surgical Management of MelanomaVadim P Koshenkov, Joe Broucek, Howard L KaufmanFrontiers in Molecular Biosciences|March 11, 2022
Talimogene Laherparepvec: Moving From First-In-Class to Best-In-ClassHoward L Kaufman, Sophia Z Shalhout, Gail IodicePageof 21